This new approach to transplanting deceased after circulatory death (DCD) hearts may offer significant benefits.

A three-institution study of 473,482 patients found the risk of an adverse event following CT contrast increases in the summer and fall.

Some of the world’s biggest names in interventional cardiology and structural heart disease gathered in Washington, D.C., for the four-day event. 

The portable device uses HeartBeam's patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthetic 12-lead ECG.

When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing. 

Scientists are people too. As such, when engaged in research projects using AI, they must resist the very human impulse to over-delegate tasks to algorithms.

The winners will present their research findings at the upcoming American Roentgen Ray Society Annual Meeting in Boston.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.